Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SeaStar Medical Holding CorpICU · Entity 7863 | Director | July 01, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SeaStar Medical Holding Corp
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001SEC Table I · non-derivative | Direct | 11,940 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 4,000 · Balance 11,940 F1: Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 2, 2026 21:08 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-022565 · rdgdoc.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 F1 · shares: Represent a restricted stock unit award ("RSU"). The RSUs will vest in full on July 1, 2027. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:58 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-003674 · rdgdoc.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,940 F1 · shares: Represents a RSU award. The RSUs will vest in full on February 6, 2027. Read SEC document |
| August 27, 2025 Filed Aug 28, 2025 21:28 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | PurchaseCommon Stock, par value $0.0001 per share | 10,000 | $0.86 | $8,565.00 |
DisclosureSEC source: 0001214659-25-013006 · marketforms-70411.xml · nonDerivative · entry 2 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,400 F2 · price: The price reported in Row 2, Column 4 is a weighted average price of $0.8565. These shares were purchased in multiple transactions at prices ranging from $0.8531 to $0.8599 inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 21:28 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | PurchaseCommon Stock, par value $0.0001 per share | 25,000 | $0.89 | $22,247.50 |
DisclosureSEC source: 0001214659-25-013006 · marketforms-70411.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,400 F1 · price: The price reported in Row 1, Column 4 is a weighted average price of $0.8899. These shares were purchased in multiple transactions at prices ranging from $0.885 to $0.89 inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 10, 2025 Filed Jul 16, 2025 23:45 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-064802 · marketforms-70100.xml · nonDerivative · entry 2 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,400 F4 · shares: Represents a RSU award. The RSUs will vest in full on July 3, 2026. Read SEC document |
| June 04, 2025 Filed Jul 16, 2025 23:45 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | Exercise / conversionRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-064802 · marketforms-70100.xml · derivative · entry 3 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.0001 per share · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ICU common stock. F6 · derivative.exercise_date: As previously reported, on November 13, 2024, the reporting person was granted 4,000 RSUs, which vested in full on June 4, 2025. F6 · derivative.expiration_date: As previously reported, on November 13, 2024, the reporting person was granted 4,000 RSUs, which vested in full on June 4, 2025. Read SEC document |
| June 04, 2025 Filed Jul 16, 2025 23:45 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | Exercise / conversionCommon Stock, par value $0.0001 per share | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-064802 · marketforms-70100.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This Form 4 is being filed to report the granting and vesting of certain restricted stock unit ("RSU") awards. F2 · shares: Reflects RSUs that upon vesting converted into shares of ICU common stock. F3 · balance_after: On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:37 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantRestricted Stock Unit · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-099149 · marketforms-67355.xml · derivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock, par value $0.0001 per share · 4,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ICU common stock. F2 · derivative.exercise_date: 100% of the restricted stock units vest on June 4, 2025. F2 · derivative.expiration_date: 100% of the restricted stock units vest on June 4, 2025. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 22:59 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 43,564 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-24-001494 · form4.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,964 F1 · shares: Represents a grant of shares of common stock, $0.0001 par value, of the Issuer (the "Common Stock") in lieu of a portion of the cash fees due to the Reporting Person for services as a director of the Issuer. Such shares are fully vested upon issuance. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:05 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | PurchaseCommon Stock, par value $0.0001 per share | 100,000 | $0.40 | $40,000.00 |
DisclosureSEC source: 0000929638-23-003222 · form4.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,400 Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 01:10 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantStock Option (Right to Buy) · Derivative | 11,967 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0000929638-23-001149 · form4.xml · derivative · entry 2 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,967 Underlying: Common Stock · 11,967 shares Expires 2033-04-06 F2 · derivative.exercise_date: All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant. Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 01:10 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 7,978 | $0.00 | $0.00 |
DisclosureSEC source: 0000929638-23-001149 · form4.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,400 F1 · shares: Represents the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest on the first anniversary of the date of grant. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 20:15 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantStock Option (Right to Buy) · Derivative | 24,483 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0000899243-22-034687 · doc4.xml · derivative · entry 2 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,483 Underlying: Common Stock · 24,483 shares Expires 2031-10-14 F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option to purchase shares of SeaStar Medical common stock was assumed and converted into an option to purchase shares of common stock of the Issuer with the same terms and conditions as were applicable to such option immediately prior to the Effective Time, subject to the applicable exchange ratio. F3 · derivative.exercise_date: The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from October 14, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from October 14, 2022. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 20:15 UTC | SeaStar Medical Holding Corp ICU · Entity 7863 | GrantCommon Stock, par value $0.0001 per share | 8,422 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-034687 · doc4.xml · nonDerivative · entry 1 Van Heel Kenneth · CIK 0001613111 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,422 F1 · kind: Represents the Issuer's common stock subject to restricted stock units (RSUs). Pursuant to the Agreement and Plan of Merger by and among the Issuer, LMF Merger Sub, Inc., and SeaStar Medical Inc. ("SeaStar Medical"), dated April 21, 2022 (as amended, the "Merger Agreement"), at the Effective Time (as defined in the Merger Agreement), each award of RSUs based on SeaStar Medical common stock that was outstanding immediately prior to the Effective Time was converted into the right to receive RSUs based on the common stock of the Issuer with the same terms and conditions as were applicable to such SeaStar Medical RSU awards immediately prior to the Effective Time, subject to the applicable exchange ratio. Fifty percent (50%) of the shares subject to RSUs reported herein will vest on the first anniversary of the Effective Time, thereafter the remaining will vest on a monthly basis over a 12-month period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.